Evaxion A EVAX
NASDAQ EVAX
$3.20 +0.02 (+0.63%)
At close: Oct 2, 2026 · 4:00 PM EDT

Evaxion A (EVAX) Other Non Operating Income (2023 - 2024)

Updated

Evaxion A (EVAX) reported Other Non Operating Income of -$190,000 for Q4 2024, compared with -$392,000 a year earlier.

Analysis

Evaxion A (EVAX) Other Non Operating Income (2023 - 2024) Analysis & Trends

  • By year, Other Non Operating Income came in at -$392,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Evaxion A 20.38 Mn -45.87 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -190,000.00
Dec 31, 2023 -392,000.00
API Access

Evaxion A Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=EVAX&period=max&api_key=YOUR_API_KEY